LncRNA SNHG1 (Small nucleolar RNA host gene 1) promotes resistance to oxaliplatin in CRC by activating the PI3K/Akt pathway, which enhances EMT, suppresses apoptosis, and boosts cell survival. Here, AKT1 is linked to colorectal carcinoma.